Compare Nuwellis Inc (NUWE) vs Under Armour Inc Class A (UA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Under Armour Inc Class A — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Under Armour Inc Class A trades at $4.82 (market cap $2.08B). The key difference: Under Armour Inc Class A is far larger — about 818.9× Nuwellis Inc's market cap, and Under Armour Inc Class A is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | UA | |
|---|---|---|
Market Cap | $2.54M | $2.08B |
Sector | Technology | Consumer Cyclical |
52-Week High | $164.50 | $7.88 |
52-Week Low | $0.73 | $3.96 |
Enterprise Value | -$1.17M | $3.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Under Armour (UA) trades at $4.95, down 3.32% today, reflecting ongoing challenges. The stock is technically bearish with weak moving averages, while fundamentals show revenue declining to $5.16B in 2025 and a net loss of -$201.27M. Negative cash flow and high debt levels add pressure, though a P/S ratio of 0.42 suggests potential undervaluation. Recent news highlights continued revenue declines and lowered guidance, signaling brand and demand headwinds.
The outlook remains cautious due to persistent losses and competitive pressures. While analyst sentiment is mixed with 40% buy ratings, risks from execution missteps and weak consumer demand outweigh near-term opportunities. Investors should focus on margin improvement and debt management for any sustainable recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Under Armour Inc Class A
Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →
